Samaille, T., Henriques, J., Tougeron, D., Piessen, G., Fouchardière, C. D. L., Louvet, C., Adenis, A., Jary, M., Garcia-Larnicol, M., Cohen, R., Vernerey, D., Lefevre, J. H., Svrcek, M., André, T. (2026). Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma: Long-term follow-up of the GERCOR NEONIPIGA phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4099